|
Written by Staff and Wire Reports
|
|
Friday, 23 March 2012 19:20 |
Below is a look at some of the headlines for companies that made news in the healthcare sector on March 23, 2012.
|
|
Read more...
|
|
Written by Staff and Wire Reports
|
|
Friday, 23 March 2012 07:48 |
They may be some of the most talked about market movers today, but companies like Alimera Sciences (Nasdaq:ALIM), Pozen (Nasdaq:POZN), Threshold Pharmaceuticals (Nasadq: THLD), Arena Pharmaceuticals (Nasdaq:ARNA) and others were once only ideas looking for early investors to back and believe in them.
|
|
Read more...
|
|
Written by M.E.Garza
|
|
Friday, 23 March 2012 06:00 |
Shares of IntelGenX Corporation (OTCBB: IGXT) were trading just under $.50 per share last November. That was the first time we told our readers the relatively under-followed story a micro-cap biotech with a pending FDA decision that could become a game changer for the company focused on improving existing medications by incorporating proprietary, advanced controlled-release technologies.
|
|
Read more...
|
|
Written by Staff and Wire Reports
|
|
Thursday, 22 March 2012 17:33 |
Below is a look at some of the headlines for companies that made news in the healthcare sector on March 22, 2012.
|
|
Read more...
|
|
Written by Michael Morhamus, Contributor
|
|
Thursday, 22 March 2012 13:42 |
Last December, I warned investors to be cautious of CytRx Corporation (CYTR) and any deal or off-spring company related to them. Now this.
|
|
Read more...
|
|
Written by George S. Mack of The Life Sciences Report
|
|
Thursday, 22 March 2012 03:59 |
The dart board will not help in picking medical technology stocks. Analyst and Managing Director William Plovanic of Canaccord Genuity focuses on the musculoskeletal/orthopedic sector, which is sensitive to factors beyond just the unmet needs of patients.
|
|
Read more...
|
|
Written by Staff and Wire Reports
|
|
Wednesday, 21 March 2012 19:59 |
Below is a look at some of the headlines for companies that made news in the healthcare sector on March 21, 2012.
|
|
Read more...
|
|
Written by Ray Dirks of Ray Dirks Research
|
|
Wednesday, 21 March 2012 00:39 |
Given some recent news, volume and interest are returning to Pluristem Therapeutics (NASDAQ:PSTI), creator of regenerative medicine based on stem cells that come from the human placenta. Once again, the stock is starting to move again.
|
|
Read more...
|
|
Written by Michael Morhamus, Contributor
|
|
Wednesday, 21 March 2012 00:00 |
Shares of Virginia based biotechnology company, CEL-SCI Corporation (AMEX: CVM) appear to be technically breaking out to the upside again. Interest and volume in the stock has been on the rise and some recent fundamental developments appear to be fuelling the price rise.
|
|
Read more...
|
|
Written by Staff and Wire Reports
|
|
Tuesday, 20 March 2012 18:58 |
Below is a look at some of the headlines for companies that made news in the healthcare sector on March 20, 2012.
|
|
Read more...
|